In a follow-up study, they were able to reveal the tumor-suppressive effect of cancer-cell-derived fibrillar collagen COL1A1 which, however, requires prior cleavage of the C-terminal pro-domain by the procollagen C-proteinase bone morphogenetic protein1 (BMP1) [25]. This evidence concerns the gene BMP1 and cancer.